Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald N Hines

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3Ronald N Hines
Pharmacology & Therapeutics|April 15, 2008
The ontogeny of drug metabolism enzymes and implications for adverse drug eventsRonald N Hines
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 16, 2003
Publication of stand-alone single nucleotide polymorphism (SNP) discovery dataRonald N Hines
Journal of Biochemical and Molecular Toxicology|October 16, 2007
Ontogeny of human hepatic cytochromes P450Ronald N Hines
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymesRonald N Hines, D Gail McCarver
Drug Metabolism Reviews|September 6, 2007
Mechanisms regulating human FMO3 transcriptionDavid E Klick, Ronald N Hines
Pediatric Clinics of North America|July 29, 2006
Pharmacogenomics and the future of drug therapyRonald N Hines, D Gail McCarver
Pharmacogenomics|November 22, 2005
Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug developmentSevasti B Koukouritaki, Ronald N Hines
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanismsD Gail McCarver, Ronald N Hines
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 2, 2014
Human hepatic UGT2B15 developmental expressionKarthika Divakaran, Ronald N Hines, D Gail McCarver
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3Ronald N Hines
Pharmacology & Therapeutics|April 15, 2008
The ontogeny of drug metabolism enzymes and implications for adverse drug eventsRonald N Hines
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 16, 2003
Publication of stand-alone single nucleotide polymorphism (SNP) discovery dataRonald N Hines
Journal of Biochemical and Molecular Toxicology|October 16, 2007
Ontogeny of human hepatic cytochromes P450Ronald N Hines
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymesRonald N Hines, D Gail McCarver
Drug Metabolism Reviews|September 6, 2007
Mechanisms regulating human FMO3 transcriptionDavid E Klick, Ronald N Hines
Pediatric Clinics of North America|July 29, 2006
Pharmacogenomics and the future of drug therapyRonald N Hines, D Gail McCarver
Pharmacogenomics|November 22, 2005
Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug developmentSevasti B Koukouritaki, Ronald N Hines
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanismsD Gail McCarver, Ronald N Hines
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 2, 2014
Human hepatic UGT2B15 developmental expressionKarthika Divakaran, Ronald N Hines, D Gail McCarver
Pageof 8